Telemedicine in Care of Sarcoma Patients beyond the COVID-19 Pandemic: Challenges and Opportunities
Cancers · 21.07.2023 · 15 (14) · 3700
DOI: 10.3390/cancers15143700 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 21.07.2023. Verfasst von Christos Tsagkaris und 3 weiteren Autor:innen. Beteiligte Einrichtung: European Student Think Tank, Public Health and Policy Working Group, 1058 DE Amsterdam, The Netherlands. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Society for Medical Oncology, Hellenic Society of Medical Oncology.
Abstract (Originalsprache)
Background
The COVID-19 pandemic has created a challenging environment for sarcoma patients. Most oncology societies published guidelines or recommendations prioritizing sarcoma patients and established telehealth as an efficient method of approaching them. The aim of this review is the assessment of current evidence regarding the utilization of telemedicine in diagnosis, treatment modalities, telerehabilitation and satisfaction among sarcoma patients and healthcare providers (HP).
Methods
This systematic review was carried out using the databases PubMed and Ovid MEDLINE according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).
Results
The application of telemedicine to the management of sarcoma has yielded improved clinical and psychological outcomes. Specifically, significant progress has been demonstrated in the areas of tele-oncology and telerehabilitation during the last decade, and the COVID-19 outbreak has accelerated this transition toward them. Telehealth has been proven efficient in a wide spectrum of applications from consultations on physical therapy and psychological support to virtual care symptom management. Both HP and patients reported satisfaction with telehealth services at levels comparable to in-person visits.
Conclusions
Telehealth has already unveiled many opportunities in tailoring individualized care, and its role in the management of sarcoma patients has been established in the post-COVID-19 era, as well.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- European Student Think Tank, Public Health and Policy Working Group, 1058 DE Amsterdam, The Netherlands.
- Department of Orthopaedics, University Hospital of Heraklion, 70013 Heraklion, Greece.
- Post Covid Department, Theme Female Health, Karolinska University Hospital, 14157 Stockholm, Sweden.
- Department of Oncology-Pathology, Karolinska Institute, 17176 Stockholm, Sweden.
- Thoracic Oncology Center, Theme Cancer, Karolinska University Hospital, 17177 Stockholm, Sweden.
- Faculty of Medicine, University of Crete, 70013 Heraklion, Greece.
ORCID-Profile: Christos Tsagkaris, Andreas Koulouris
Förderung
- European Society for Medical Oncology
- Hellenic Society of Medical Oncology
Zitieren
APA
Tsagkaris, C., Trygonis, N., Spyrou, V., & Koulouris, A. (2023). Telemedicine in Care of Sarcoma Patients beyond the COVID-19 Pandemic: Challenges and Opportunities. Cancers, 15(14), 3700. https://doi.org/10.3390/cancers15143700
Vancouver
Tsagkaris C, Trygonis N, Spyrou V, Koulouris A. Telemedicine in Care of Sarcoma Patients beyond the COVID-19 Pandemic: Challenges and Opportunities. Cancers. 2023;15(14):3700. doi:10.3390/cancers15143700
BibTeX
@article{Tsagkaris2023,
author = {Tsagkaris, Christos and Trygonis, Nikolaos and Spyrou, Vasiliki and Koulouris, Andreas},
title = {Telemedicine in Care of Sarcoma Patients beyond the COVID-19 Pandemic: Challenges and Opportunities},
journal = {Cancers},
year = {2023},
volume = {15},
number = {14},
pages = {3700},
doi = {10.3390/cancers15143700}
}
EUVIMED